Key Highlights
- Altria (MO) reached a fresh 52-week peak of $76.17, closing at $76.48
- First quarter earnings per share of $1.32 surpassed analyst estimates of $1.25; revenue of $4.76B exceeded forecasts by $180M
- Company projects full-year 2026 EPS between $5.56 and $5.72
- Current quarterly dividend stands at $1.06 per share, delivering a 5.5% yield
- Wall Street analysts maintain a “Hold” consensus with a $70.78 average price target
Shares of MO reached a new yearly peak during Tuesday’s session, climbing to $76.17 before closing near $76.48 — a significant jump from the previous day’s close of $72.89. The tobacco giant’s stock has surged 30.45% since the beginning of the year and has delivered a 32.55% return over the trailing 12 months.
This upward momentum follows an impressive quarterly performance. The company reported earnings per share of $1.32, comfortably exceeding the $1.25 consensus estimate. Quarterly revenue reached $4.76 billion, marking a 5.3% increase from the prior year period and surpassing Wall Street’s $4.58 billion projection.
Looking ahead to fiscal 2026, management has established EPS guidance ranging from $5.56 to $5.72. The Street’s current estimate sits at $5.70 for the full year.
Income Investors Remain Attracted to Steady Payouts
Altria distributed a quarterly dividend of $1.06 per share on July 10, translating to an annual distribution of $4.24 and yielding approximately 5.5%. This marks the 56th consecutive year the company has maintained dividend payments.
While the payout ratio stands at an elevated 88.7%, the reliable income stream continues to draw investors seeking yield in their portfolios.
Recent insider activity showed two board members reducing their holdings in May. Director Debra J. Kelly divested 5,790 shares at $72.25 per share, trimming her stake by 7.27%. Similarly, Ellen R. Strahlman sold 2,000 shares at $72.56, representing a 7.38% reduction in her position. Both transactions were properly filed with the SEC.
Institutional ownership accounts for 57.41% of outstanding shares. Multiple institutional investors have expanded their positions in recent months, including Bernardo Wealth Planning, which boosted its holdings by 4.6% during the second quarter.
Wall Street Perspectives Remain Divided
Analyst sentiment toward MO currently registers as “Hold,” with a consensus price target of $70.78 — noticeably below the stock’s current trading level.
UBS maintains a Buy recommendation with a $79 price objective. Bank of America revised its projections following beneficial regulatory developments in the tobacco industry during Q2. BTIG launched coverage in July with a Neutral stance.
Citigroup upgraded its price target from $65 to $70 while keeping a Neutral rating. Morgan Stanley maintains a $71 target price. Jefferies carries an Underperform rating with a $60 objective. Among the dozen analysts tracking the stock, five recommend buying, five suggest holding, and two advocate selling.
The FDA recently unveiled a proposed regulation requiring foreign tobacco manufacturers to register their production facilities. This regulatory shift is viewed favorably for domestic manufacturers such as Altria.
Data from Bank of America indicates that oral tobacco product sales experienced growth through late May, while traditional cigarette and vaping product sales continued their decline.
MO currently commands a market capitalization of $127.82 billion, trades at a price-to-earnings multiple of 16.01, and exhibits a beta of 0.45. The stock’s 50-day moving average sits at $71.90, while its 200-day moving average stands at $67.95.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
